Global Rare Disease Registry

Global Rare Disease Registry
Name	Global Rare Disease Registry
Type	International patient registry
Established	2020s
Headquarters	Geneva
Languages	English, French, Spanish
Coordinates	46.2044° N, 6.1432° E

Global Rare Disease Registry is an international initiative to aggregate clinical, genomic, and epidemiological data on rare diseases to accelerate diagnosis, treatment, and policy. It connects stakeholders across continents including patient advocacy groups, academic consortia, pharmaceutical companies, and multilateral agencies to create a federated dataset for research and clinical decision-making. The registry aligns with global standards and ethical frameworks to support translational science, regulatory submissions, and public health planning.

Introduction

The registry emerged through collaboration among entities such as World Health Organization, European Medicines Agency, Food and Drug Administration, National Institutes of Health, and European Commission with input from networks like Orphanet, Global Genes, Rare Diseases International, EURORDIS, and International Rare Diseases Research Consortium. It interfaces with academic centers including Harvard Medical School, University of Oxford, Karolinska Institutet, University of Toronto, and University of Tokyo as well as industry partners such as Roche, Pfizer, Novartis, Sanofi, and Johnson & Johnson. The initiative draws on precedent projects like Global Alliance for Genomics and Health, All of Us Research Program, UK Biobank, ClinGen, and DECIPHER.

Purpose and Scope

Primary objectives mirror mandates from United Nations, World Health Assembly, and patient-led agendas from Coalition of Cancer Cooperative Groups and Rare Diseases International to reduce diagnostic odysseys and improve therapies. Scope includes longitudinal clinical phenotypes, whole-genome sequences, imaging from centers such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, and biospecimen metadata in alignment with repositories like European Genome-phenome Archive and dbGaP. The registry supports regulatory science for orphan drug pathways overseen by European Medicines Agency and Food and Drug Administration and harmonizes with coding schemes from World Health Organization ICD and ontologies like Human Phenotype Ontology.

Governance and Ethics

Governance frameworks reference charters from Council of Europe, World Health Organization Framework Convention on Tobacco Control for treaty-style coordination, and ethical guidance from Declaration of Helsinki, Belmont Report, and Nuremberg Code. Oversight boards include representation from Patient-Centered Outcomes Research Institute, national health ministries, academic ethicists from Johns Hopkins Bloomberg School of Public Health and Harvard T.H. Chan School of Public Health, and legal advisors familiar with General Data Protection Regulation and Health Insurance Portability and Accountability Act of 1996. Equity considerations engage organizations such as UNICEF, World Bank, and Bill & Melinda Gates Foundation.

Data Standards and Interoperability

Technical standards adopt profiles and vocabularies from Fast Healthcare Interoperability Resources, LOINC, SNOMED CT, Human Phenotype Ontology, and Gene Ontology and integrate data models used by Observational Medical Outcomes Partnership and OMOP Common Data Model. FAIR principles promoted by GO FAIR and data-sharing agreements modeled on Creative Commons licenses guide reuse. Interoperability testing involves infrastructure from Global Alliance for Genomics and Health, cloud platforms like Amazon Web Services, Google Cloud Platform, and Microsoft Azure, and identity frameworks influenced by OpenID Foundation and OAuth.

Participant Recruitment and Consent

Recruitment strategies coordinate with patient advocacy groups including EURORDIS, NORD, Genetic Alliance, Cystic Fibrosis Foundation, and clinical trial networks such as European Reference Networks and ClinicalTrials.gov. Consent processes align with models from Informed Consent Committee, dynamic consent pilots from University of Oxford and community engagement practices from African Academy of Sciences. Special protections reference precedents in Convention on Human Rights and Biomedicine and pediatric assent guidelines used at Great Ormond Street Hospital.

Data Security and Privacy

Security regimes employ encryption standards from National Institute of Standards and Technology and cybersecurity frameworks informed by European Union Agency for Cybersecurity and incident response practices used by CERT Coordination Center. Privacy protections map to General Data Protection Regulation, Health Insurance Portability and Accountability Act of 1996, and national privacy statutes in United Kingdom, United States, Canada, Australia, and Japan. De-identification methods reference techniques validated by Centers for Disease Control and Prevention and re-identification risk analyses used in projects at Massachusetts Institute of Technology.

Research Uses and Clinical Applications

Data support natural history studies modeled after work at National Institutes of Health, biomarker discovery similar to efforts at Broad Institute, and drug repurposing pipelines followed by Repurposing Drugs in Oncology Consortium. Clinical decision support tools integrate algorithms developed in collaborations with Stanford Medicine, MIT, Imperial College London, and regulatory submissions to European Medicines Agency and Food and Drug Administration. Outcomes measures reference standards from International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and health economics analyses informed by Organisation for Economic Co-operation and Development.

Challenges and Future Directions

Key challenges mirror those confronted by Human Genome Project, HITSP, and multinational consortia such as aligning cross-border law, sustainable financing from sources like Wellcome Trust and Horizon Europe, and ensuring inclusion of underrepresented regions via partnerships with African Union, Pan American Health Organization, and Asia-Pacific Economic Cooperation. Future directions include integrating single-cell datasets from ENCODE Project, federated learning approaches like those piloted by Personalized Medicine Coalition, and regulatory harmonization efforts similar to International Council for Harmonisation to accelerate orphan drug development while protecting participant rights.

Category:Medical registries